Irvine, CA, United States of America

Peter Condorelli


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2003-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Lung Health: The Contributions of Peter Condorelli

Introduction

Peter Condorelli is an accomplished inventor based in Irvine, CA, known for his significant contributions to the field of respiratory health. With a total of 5 patents, his work focuses on non-invasive techniques to characterize inflammatory lung diseases. His innovative approaches have the potential to enhance diagnostic methods and improve patient outcomes.

Latest Patents

Among his latest patents, Condorelli has developed a method for flow-independent parameter estimation based on tidal breathing exhalation profiles. This technique utilizes a two-compartment model to characterize nitric oxide (NO) gas exchange in the lungs. By applying this model, he can estimate up to six flow-independent parameters and study various breathing patterns. Another notable patent involves an accurate method to characterize airway nitric oxide using different breath-hold times. This apparatus and method diagnose lung disease states by measuring airway NO parameters during a series of breath-hold maneuvers.

Career Highlights

Throughout his career, Condorelli has worked with prestigious organizations, including the University of California and Fluor Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Steven C. George and Ray Won. Their collaborative efforts have further advanced the understanding of lung health and the development of innovative diagnostic techniques.

Conclusion

Peter Condorelli's contributions to respiratory health through his patents and collaborations highlight the importance of innovation in medical diagnostics. His work continues to pave the way for improved understanding and treatment of lung diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…